What are TRXB's recent SEC filings?
8-K · OtherOct 13, 2026
TRex Bio, Inc. filed an 8-K reporting the effectiveness of its Fourth Amended and Restated Certificate of Incorporation and Second Amended and Restated Bylaws in connection with the consummation of its initial public offering. The amended charter authorizes 225 million shares of common stock and 25 million shares of undesignated preferred stock, and eliminates stockholders' ability to act by written consent.
View full filing details →Authorized shares of common stock: $225.0M, Authorized shares of undesignated preferred stock: $25.0M
Has TRXB ever done a stock split?
No stock splits are recorded for TRXB.
Get Real-Time TRXB Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free